A Chewable Pediatric Fixed-dose Combination Tablet of Stavudine, Lamivudine, and Nevirapine

201031 citationsJournal Articlegreen Open Access

Authors

Nirun Vanprapar · Siriraj Hospital

Tim R. Cressey · Baystate Medical Center

Kulkanya Chokephaibulkit · Siriraj Hospital

Petronella Muresan · Baystate Medical Center

Nottasorn Plipat · National Institutes of Health

Virat Sirisanthana · Boston Children's Hospital

Wasana Prasitsuebsai

Abstract

The chewable FDC was safe and provided therapeutically adequate plasma drug exposures in human immunodeficiency virus-infected children. Substituting the FDC for liquid formulations can simplify antiretroviral therapy.

Topics & Keywords

HIV/AIDS drug development and treatment HIV Research and Treatment HIV/AIDS Research and Interventions

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The Pediatric Infectious Disease Journal

Volume 29, Issue 10, pp. 940-944

DOI: 10.1097/inf.0b013e3181e2189d

Field-Weighted Citation Impact: 1.53